Intensive treatment of type 1 diabetes

被引:35
作者
Hirsch, IB [1 ]
机构
[1] Univ Washington, Med Ctr, Sch Med,Dept Med, Diabet Care Ctr,Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
关键词
D O I
10.1016/S0025-7125(05)70020-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There has been a dramatic evolution in the management of type 1 diabetes. Although clinicians' abilities to manage glycemia are still far from perfect, new tools have improved the ability to maintain near-normal glycemia. This article focuses on all of the available tools, both new and old. Although the use of insulin is emphasized, it is clear that the management of type 1 diabetes relies on many factors and, like all therapies, risks are involved.
引用
收藏
页码:689 / +
页数:33
相关论文
共 148 条
[1]  
Agardh Carl-David, 1992, Journal of Diabetes and its Complications, V6, P96, DOI 10.1016/1056-8727(92)90018-G
[2]   THE IMPACT OF THE TRIAL COORDINATOR IN THE DIABETES CONTROL AND COMPLICATIONS TRIAL (DCCT) [J].
AHERN, J ;
GROVE, N ;
STRAND, T ;
WESCHE, J ;
SEIBERT, C ;
BRENNEMAN, AT ;
TAMBORLANE, WV .
DIABETES EDUCATOR, 1993, 19 (06) :509-512
[3]  
*AM DIAB ASS, 1995, INT DIAB MAN
[4]  
*AM DIAB ASS, 1997, DIABETES CARE S1, V20, pS5
[5]   PHYSIOLOGICAL-RESPONSES TO HYPOGLYCEMIA - COUNTERREGULATION AND COGNITIVE FUNCTION [J].
AMIEL, SA ;
GALE, E .
DIABETES CARE, 1993, 16 :48-55
[6]   DEFECTIVE GLUCOSE COUNTERREGULATION AFTER STRICT GLYCEMIC CONTROL OF INSULIN-DEPENDENT DIABETES-MELLITUS [J].
AMIEL, SA ;
TAMBORLANE, WV ;
SIMONSON, DC ;
SHERWIN, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (22) :1376-1383
[7]   INTENSIFIED INSULIN THERAPY [J].
AMIEL, SA .
DIABETES-METABOLISM REVIEWS, 1993, 9 (01) :3-24
[8]   NUTRITION INTERVENTIONS FOR INTENSIVE THERAPY IN THE DIABETES CONTROL AND COMPLICATIONS TRIAL [J].
ANDERSON, EJ ;
RICHARDSON, M ;
CASTLE, G ;
CERCONE, S ;
DELAHANTY, L ;
LYON, R ;
MUELLER, D ;
SNETSELAAR, L .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1993, 93 (07) :768-772
[9]   Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment [J].
Anderson, JH ;
Brunelle, RL ;
Koivisto, VA ;
Pfutzner, A ;
Trautmann, ME ;
Vignati, L ;
DiMarchi, R ;
Bowen, KM ;
Cameron, DP ;
Nankervis, AJ ;
Roberts, AP ;
Zimmet, P ;
Borkenstein, MH ;
Schernthaner, G ;
Waldhausl, WK ;
DeLeeuw, IH ;
Fery, F ;
Scheen, A ;
Somers, G ;
Fettes, IM ;
Tildesley, HD ;
Toth, EL ;
Viikari, J ;
Altman, JJ ;
Bougneres, PF ;
Drouin, P ;
Fossati, P ;
Guillausseau, PJ ;
Marechaud, E ;
Riou, JP ;
Selam, JL ;
Vialettes, PB ;
Beyer, J ;
Federlin, K ;
Fussganger, RD ;
Gries, FA ;
Jastram, HU ;
Koop, I ;
Landgraf, R ;
Rosak, C ;
Schatz, H ;
SchulzeSchleppinghoff, B ;
Seif, FJ ;
Stoeckmann, F ;
Karasik, A ;
Weitzman, S ;
Andreani, D ;
Bompiani, G ;
Crepaldi, G ;
Giorgino, R .
DIABETES, 1997, 46 (02) :265-270
[10]  
[Anonymous], 1988, JAMA, V260, P37